Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan

Hepatol Int. 2023 Oct;17(5):1215-1224. doi: 10.1007/s12072-023-10557-2. Epub 2023 Jul 26.

Abstract

Background/purpose: Primary sclerosing cholangitis (PSC) is a rare chronic liver disease. The mechanisms and prediction of PSC progression are unclear. Recent investigations have shown that general conditions, such as oxidative stress, affect the course of chronic diseases. We investigated the clinical course and oxidative stress-related condition of PSC to determine prognostic factors.

Methods: We recruited 58 patients with PSC (mean age; 37.4 years, mean observation period; 1382 days) who visited our department from 2003 to 2021. Clinical characteristics were investigated to define prognostic factors. Oxidative stress status was evaluated using two types of markers: an oxidative stress marker (serum reactive oxygen metabolite; dROM) and an antioxidant marker (serum OXY adsorbent test; OXY).

Results: The revised Mayo risk, Child-Pugh, model for end-stage liver disease-sodium (MELD-Na) scores or fibrosis-related FIB-4 index significantly predicted poor overall survival. High intestinal immunoglobulin A (IgA) levels predicted poor survival. Among patients with high and intermediate revised Mayo risk scores, those with physiologically high dROM levels showed better survival than those with lower dROM levels. In this population, dROM was negatively correlated with AST and IgA, which are both correlated with survival.

Conclusions: High and intermediate revised Mayo risk score group predicted a poor clinical course in PSC. Additionally, the Child-Pugh score, MELD-Na score, FIB-4 index, and serum IgA were significantly correlated with survival. In patients with high and intermediate revised Mayo risk scores, physiologically high oxidative stress status correlated with low IgA levels and a good prognosis.

Keywords: Child–Pugh score; FIB-4 index; Immunoglobulin A; MELD score; Oxidative stress marker; Primary sclerosing cholangitis; Prognosis; Revised Mayo risk score; Serum OXY-adsorbent test; Serum dROM; Serum reactive oxygen metabolite; Total serum antioxidant capacity.

MeSH terms

  • Cholangitis, Sclerosing*
  • Disease Progression
  • End Stage Liver Disease*
  • Humans
  • Immunoglobulin A
  • Japan
  • Oxidative Stress
  • Prognosis
  • Retrospective Studies
  • Severity of Illness Index

Substances

  • Immunoglobulin A